Role of epigenetics in pancreatic ductal adenocarcinoma

S Pandey, VK Gupta, SP Lavania - Epigenomics, 2023 - Taylor & Francis
Pancreatic ductal adenocarcinoma (PDAC) is one of the most aggressive cancers,
associated with poor survival outcomes. Lack of early diagnosis, resistance to conventional …

[HTML][HTML] A novel role of TGFBI in macrophage polarization and macrophage-induced pancreatic cancer growth and therapeutic resistance

J Zhou, N Lyu, Q Wang, M Yang, ET Kimchi, K Cheng… - Cancer letters, 2023 - Elsevier
Abstract Tumor-associated macrophages (TAMs), as a major and essential component of
tumor microenvironment (TME), play a critical role in orchestrating pancreatic cancer (PaC) …

Natural biomolecules and derivatives as anticancer immunomodulatory agents

S Bernitsa, R Dayan, A Stephanou… - Frontiers in …, 2023 - frontiersin.org
Despite advancements in chemotherapy, the issue of resistance and non-responsiveness to
many chemotherapeutic drugs that are currently in clinical use still remains. Recently …

Inhibition of autophagy induced by tetrandrine promotes the accumulation of reactive oxygen species and sensitizes efficacy of tetrandrine in pancreatic cancer

Y Wang, T Xu, H Wang, G Xia, X Huang - Cancer Cell International, 2024 - Springer
Pancreatic cancer, characterized by its poor prognosis, exhibits a marked resistance to
conventional chemotherapy and immunotherapy, underscoring the urgent need for more …

Therapeutic Strategies for Pancreatic-Cancer-Related Type 2 Diabetes Centered around Natural Products

MN Park - International Journal of Molecular Sciences, 2023 - mdpi.com
Pancreatic ductal adenocarcinoma (PDAC), a highly malignant neoplasm, is classified as
one of the most severe and devastating types of cancer. PDAC is a notable malignancy that …

Dual activity of Minnelide chemosensitize basal/triple negative breast cancer stem cells and reprograms immunosuppressive tumor microenvironment

F Koksalar Alkan, AB Caglayan, HK Alkan, E Benson… - Scientific Reports, 2024 - nature.com
Triple negative breast cancer (TNBC) subtype is characterized with higher EMT/stemness
properties and immune suppressive tumor microenvironment (TME). Women with advanced …

Cancer-associated fibroblasts as therapeutic targets for cancer: advances, challenges, and future prospects

Z Cao, S Quazi, S Arora, LD Osellame… - Journal of Biomedical …, 2025 - Springer
Research into cancer treatment has been mainly focused on developing therapies to directly
target cancer cells. Over the past decade, extensive studies have revealed critical roles of …

Antitumor mechanisms and future clinical applications of the natural product triptolide

S Bao, M Yi, B Xiang, P Chen - Cancer Cell International, 2024 - Springer
Triptolide (TPL) is a compound sourced from Tripterygium wilfordii Hook. F., a traditional
Chinese medicinal herb recognized for its impressive anti-inflammatory, anti-angiogenic …

[PDF][PDF] Pharmacological activity and clinical progress of Triptolide and its derivatives LLDT-8, PG490-88Na, and Minnelide: a narrative review.

LS Zeng, P Yang, YY Qin, WH He… - European Review for …, 2023 - europeanreview.org
Triptolide, a compound isolated from a Chinese medicinal herb, has potent antitumor,
immunosuppressive, and anti-inflammatory properties. Due to its interesting structural …

[HTML][HTML] Potential antitumor activity of triptolide and its derivatives: Focused on gynecological and breast cancers

M Li, J Li, Q Tang, Y Zhu - Biomedicine & Pharmacotherapy, 2024 - Elsevier
Cancer remains one of the greatest global health concerns. This is especially true for
gynecological cancers, which include cervical, ovarian, and endometrial cancers, and breast …